УПОТРЕБЛЕНИЕ ПСИХОАКТИВНЫХ ВЕЩЕСТВ КАК ФАКТОР КРИМИНАЛЬНОЙ АГРЕССИИ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ
Обзорная статья
Дата публикации: июня 7, 2024
Ключевые слова
насилие
преступность
преступность
Как цитировать
Искандаров Р. Р. УПОТРЕБЛЕНИЕ ПСИХОАКТИВНЫХ ВЕЩЕСТВ КАК ФАКТОР КРИМИНАЛЬНОЙ АГРЕССИИ: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ // Кремлевская медицина. Клинический вестник. 2024. Т. № 2. С. 82-87.
Аннотация
В статье представлен обзор и систематизированы современные представления о взаимосвязи употребления психоактивных веществ (ПАВ) и агрессивного поведения, носящего криминальный характер. Описаны механизмы формирования агрессии под воздействием алкоголя и наиболее распространенных наркотиков. Приведены основные биологические, психологические и социальные факторы агрессивного поведения и риска виктимизации под воздействием ПАВ. Применен общенаучный метод: анализ актуальных источников, касающихся состояния проблемы, с использованием систем Google Scholar, PubMed и eLibrary.Литература
1. The State Anti-Drug Committee. Report on the drug situation in the Russian Federation in 2022 (excerpt). In Russian. URL: https://media.mvd.ru/files/embed/4905796.
2. UNODC, United Nations Office on Drugs and Crime, World Drug Report. – 2012. URL: https://www.unodc.org/unodc/fr/data-and-analysis/WDR-2012.html.
3. WHO, World Health Organization, World Health Report. – 2002. URL: https://www.who.int/publications/i/item/9241562072.
4. German S. et al. Direct and indirect forms of non-suicidal self-injury: evidence for a distinction // Psychiatry Research. – 2016. – V. 197. – No 1. – P. 78–84. DOI: 10.1016/j.psychres.2011.12.050.
5. Dragisic T. Drug addiction as risk for suicide attempts // Mater. Sociomed. – 2015. – V. 7. – No 3. – P. 188–191. DOI: 10.5455/msm.2015.27.188-191.
6. McAllister M. Multiple meanings of self-harm: A critical review // International Journal of Mental Health Nursing. – 2003. – V. 12. – P. 177–185. DOI: 10.1046/j.1440-0979.2003.00287.x.
7. Whitlock J. Self-injurious behavior in adolescents // PLoS Med. – 2010. – V. 7. – No 5. – P. e1000240. DOI: 10.1371/journal.pmed.1000240.
8. Hillis S. et al. Global prevalence of past-year violence against children: a systematic review and minimum estimates // Pediatrics. – 2016. – V. 137. – No 3. – P. e20154079. DOI: 10.1542/peds.2015-4079.
9. Kepple N. The complex nature of parental substance use: examining past year and prior use behaviors as correlates of child maltreatment frequency // Subst. Use Misuse. – 2017. – V. 52. – No 6. – P. 811–821. DOI: 10.1080/10826084.2016.1253747.
10. Elwyn L. et al. Child Maltreatment and Adult Substance Abuse: The Role of Memory // J. Soc. Work Pract. Addict. – 2013. – V. 13. – No 3. – P. 10.1080/1533256X.2013.814483. DOI: 10.1080/1533256X.2013.814483.
11. Casadio P. et al. Personality disorders in addiction outpatients: prevalence and effects on psychosocial functioning // Subst. Abuse. – 2014. – V. 31. – No 8. – P. 17–24. DOI: 10.4137/SART.S13764.
12. Cottler L. Subtypes of adult antisocial behavior among drug abusers // J. Nerv. Ment. Dis. – 1995. – V. 183. – No 3. – P. 154–161. DOI: 10.1097/00005053-199503000-00005.
13. Tielbeek J. Genetic correlation of antisocial behaviour with alcohol, nicotine, and cannabis use // Drug Alcohol Depend. – 2018. – V. 187. – P. 296–299. DOI: 10.1016/j.drugalcdep.2018.03.020.
14. Allroggen M. The prevalence of sexual violence // Dtsch Arztebl Int. – 2016. – V. 113. – No 7. – P. 107–113. DOI: 10.3238/arztebl.2016.0107.
15. Do V. et al. Sexual violence and the risk of HIV transmission in sexual partners of male injecting drug users in Tien Du district, Bac Ninh province of Vietnam // Health Care Women Int. – 2018. – V. 39. – No 4. – P. 404–414. DOI: 10.1080/07399332.2017.1423315.
16. Liakoni E. Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland // PLoS One. – 2018. – V. 13. – No 3. DOI: 10.1371/journal.pone.0195234.
17. Goldstein P. The drugs/violence nexus: A tripartite conceptual framework // J. Drug Issues. – 1985. – V. 15. – No 4. – P. 493–506.
18. Žarkovic P. Psychiatric comorbidity in forensic psychiatry // Psychiatria Danubina. – 2009. – V. 21. – No 3. – P. 429–436.
19. Coomber K. The role of illicit drug use in family and domestic violence in Australia // J. Interpers. Violence. – 2021. – V. 36. – No 15–16. – P. NP8247–NP8267. DOI: 10.1177/0886260519843288.
20. Substance Abuse and Mental Health Services Administration (SAMHSA) behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. – 2014. URL: https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.htm
21. Mounteney J. et al. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015 // Addiction. – 2016. – V. 111. – № 1. – P. 34–48. DOI:10.1111/add.13056.
22. Stompe T. et al. Patterns of substance abuse in offenders with schizophrenia: illness-related or criminal life-style? // Frontiers in Psychiatry. – 2019. – V. 9. – P. 10. DOI: 10.3389/fpsyt.2018.00233.
23. Erkiran M. Substance abuse amplifies the risk for violence in schizophrenia spectrum disorder // Addict. Behav. – 2006. – V. 31. – P. 1797–1805. DOI: 10.1016/j.addbeh.2005.12.024.
24. Maremmani I. et al. Does dual diagnosis affect violence and moderate/superficial self-harm in heroin addiction at treatment entry? // J. Addict. Med. – 2014. – V. 8. – P. 116–122. DOI: 10.1097/ADM.0000000000000019.
25. Ataev D.A. et al. Bipolar disorder and drug addiction // Abstracts of the All-Russian scientific and practical conference of young scientists with international participation. – Moscow: FSBI DPO “TSGMA”. – 2023. – P. 11–13. In Russian.
26. Lewis C. Substance use and violent behavior in women with antisocial personality disorder // Behav. Sci. Law. – 2011. – V. 29. – P. 667–676. DOI: 10.1002/bsl.1006.
27. Corkery J. et al. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1.4 butanediol (1.4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use // Neuroscience and Biobehavioral Reviews. – 2015. – V. 53. – P. 52–78. DOI: 10.1016/j.neubiorev.2015.03.012.
28. Corkery J. et al. Mephedrone-related fatalities in the United Kingdom: contextual, clinical and practical issues // Pharmacology Open Access Publisher. – 2012. – P. 355–380.
29. Chiappini S. et al. Methoxetamine-related deaths in the UK: an overview // Human Psychopharmacology: Clinical and Experimental. – 2015. – V. 30. – No 4. – P. 244–248. DOI: 10.1002/hup.2422.
30. Kuypers K. et al. Intoxicated aggression: Do alcohol and stimulants cause dose-related aggression? A review // Eur. Neuropsychopharmacol. – 2020. – V. 30. – P. 114–147. DOI: 10.1016/j.euroneuro.2018.06.001.
31. Gillet C. et al. Acting out and psychoactive substances: alcohol, drugs, illicit substances // Encephale. – 2001. – V. 27. – No 4. – P. 351–359. PMID: 11686057.
32. Vaughn M. et al. Crime and violence among MDMA Users in the United States // AIMS Public Health. – 2015. – V. 18. – No 2. – P. 64–73. DOI: 10.3934/publichealth.2015.1.64.
33. Wood D. et al. Prevalence of use and acute toxicity associated with the use of NBOMe drugs // Clin. Toxicol. – 2015. – V. 53. – P. 85–92. DOI: 10.3109/15563650.2015.1004179.
34. Saxon L. et al. Reduction of aggression during benzodiazepine withdrawal: Effects of flumazenil // Pharmacol. Biochem. Behav. – 2010. – V. 96. – No 2. – P. 148–151. DOI: 10.1016/j.pbb.2010.04.023.
35. Papanti D. “Spiceophrenia”: a systematic overview of “spice”-related psychopathological issues and a case report // Hum. Psychopharmacol. – 2013. – V. 28. – No 4. – P. 379–89. DOI: 10.1002/hup.2312.
36. Roberts L. 11 analytically confirmed cases of mexedrone use among polydrug users // Clin. Toxicol (Phila). – 2017. – V. 55. – No 3. – P. 181–186. DOI: 10.1080/15563650.2016.1271424.
37. Schifano F. et al. Psychonaut Web Mapping; ReDNet Research Groups. Mephedrone (4-methylmethcathinone; “meow meow”): chemical, pharmacological and clinical issues // Psychopharmacology (Berl). – 2011. – V. 214. – No 3. – P. 593–602. DOI: 10.1007/s00213-010-2070-x.
38. James D. et al. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service // Emerg. Med. J. – 2011. – V. 28. – No 86. – P. 689. DOI: 10.1136/emj.2010.096636.
39. Schifano F. Substance misuse in the workplace. In: Ghodse A.H. (ed). Addiction at work: tackling drug use and misuse in the workplace // Gower Publishing Ltd, Aldershot (UK). – 2005. – P. 53–67.
40. Barthelemy O. Prenatal, perinatal, and adolescent exposure to marijuana: Relationships with aggressive behaviour // Neurotoxicol. Teratol. – 2016. – V. 58. – P. 60–77. DOI: 10.1016/j.ntt.2016.06.009.
41. Martinotti G. et al. Substance‐related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza // Hum. Psychopharmacol. Clin. Exp. – 2017. – V. 32. – No 3. DOI: 10.1002/hup.2586.
42. Kolla N. et al. The endocannabinoid system, aggression, and the violence of synthetic cannabinoid use, borderline personality disorder, antisocial personality disorder, and other psychiatric disorders // Front. Behav. Neurosci. – 2018. – V. 12. – P. 41. DOI: 10.3389/fnbeh.2018.00041.
43. Brooks J. Serum testosterone in violent and nonviolent young offenders // J. Clin. Psychol. – 1996. – V. 52. – No 4. – P. 475–83. DOI: 10.1002/(SICI)1097-4679(199607)52:4<475::AID-JCLP14>3.0.CO;2-D.
44. Wang J. et al. Self-directed violence after medical emergency department visits among youth // Am. J. Prevent. Med. – 2019. – V. 56. – No 2. – P. 205–214. DOI: 10.1016/j.amepre.2018.09.014.
45. Mauri M. Aggression and psychopharmacological treatments in major psychosis and personality disorders during hospitalization // Progress in Neuro-Psychopharmacology and Biological Psychiatry. – 2011. – V. 35. – No 7. – P. 1631–1635. DOI: 10.1016/j.pnpbp.2011.05.008.
46. Swanson J. et al. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia // The British Journal of Psychiatry. – 2008. – V. 193. – No 1. – P. 37–43. DOI: 10.1192/bjp.bp.107.042630.
47. Martinotti G. et al. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients // Hum. Psychopharmacol. – 2007. – V. 22. – P. 149–156. DOI: 10.1002/hup.833.
48. Schifano F. NPS: Medical consequences associated with their intake // Curr. Top. Behav. Neurosci. – 2017. – V. 32. – P. 351–380. doi: 10.1007/7854_2016_15.
49. Iskandarov R.R. et al. Risk factors and predictors of aggressive behavior of convicted men with post-traumatic stress disorder // Social and Clinical Psychiatry. – 2013. – V. 23. – No 2. – P. 21 – 28. In Russian.
50. Vilkova A.V. et al. Psychological support of juvenile convicts in educational colonies of the penal correctional system of the Russian Federation // To the 80th anniversary of the birth of Doctor of Pedagogical Sciences, Professor V.M. Litvishkov: collection of materials of the round table. – Ryazan: FCU NIIT. – 2023. – P. 141–145. In Russian.
51. Balamut A.N. Conducting sessions on psychotherapeutic areas of work with different categories of inmates: a practical guide // Vologda Institute of Law and Economics. – Vologda: Vologda Institute of Law and Economics of the Federal Service for the Execution of Punishments. – 2017. – 97 p. In Russian.
52. Kryazheva S.G. Studying the personality of a life convict as a condition for effective operational and investigative prevention // Psychology and Law. – 2023. – V. 13. – No 2. – P. 127–142. DOI: 10.17759/psylaw.2023130210. In Russian. DOI:10.17759/psylaw.2023130210.
2. UNODC, United Nations Office on Drugs and Crime, World Drug Report. – 2012. URL: https://www.unodc.org/unodc/fr/data-and-analysis/WDR-2012.html.
3. WHO, World Health Organization, World Health Report. – 2002. URL: https://www.who.int/publications/i/item/9241562072.
4. German S. et al. Direct and indirect forms of non-suicidal self-injury: evidence for a distinction // Psychiatry Research. – 2016. – V. 197. – No 1. – P. 78–84. DOI: 10.1016/j.psychres.2011.12.050.
5. Dragisic T. Drug addiction as risk for suicide attempts // Mater. Sociomed. – 2015. – V. 7. – No 3. – P. 188–191. DOI: 10.5455/msm.2015.27.188-191.
6. McAllister M. Multiple meanings of self-harm: A critical review // International Journal of Mental Health Nursing. – 2003. – V. 12. – P. 177–185. DOI: 10.1046/j.1440-0979.2003.00287.x.
7. Whitlock J. Self-injurious behavior in adolescents // PLoS Med. – 2010. – V. 7. – No 5. – P. e1000240. DOI: 10.1371/journal.pmed.1000240.
8. Hillis S. et al. Global prevalence of past-year violence against children: a systematic review and minimum estimates // Pediatrics. – 2016. – V. 137. – No 3. – P. e20154079. DOI: 10.1542/peds.2015-4079.
9. Kepple N. The complex nature of parental substance use: examining past year and prior use behaviors as correlates of child maltreatment frequency // Subst. Use Misuse. – 2017. – V. 52. – No 6. – P. 811–821. DOI: 10.1080/10826084.2016.1253747.
10. Elwyn L. et al. Child Maltreatment and Adult Substance Abuse: The Role of Memory // J. Soc. Work Pract. Addict. – 2013. – V. 13. – No 3. – P. 10.1080/1533256X.2013.814483. DOI: 10.1080/1533256X.2013.814483.
11. Casadio P. et al. Personality disorders in addiction outpatients: prevalence and effects on psychosocial functioning // Subst. Abuse. – 2014. – V. 31. – No 8. – P. 17–24. DOI: 10.4137/SART.S13764.
12. Cottler L. Subtypes of adult antisocial behavior among drug abusers // J. Nerv. Ment. Dis. – 1995. – V. 183. – No 3. – P. 154–161. DOI: 10.1097/00005053-199503000-00005.
13. Tielbeek J. Genetic correlation of antisocial behaviour with alcohol, nicotine, and cannabis use // Drug Alcohol Depend. – 2018. – V. 187. – P. 296–299. DOI: 10.1016/j.drugalcdep.2018.03.020.
14. Allroggen M. The prevalence of sexual violence // Dtsch Arztebl Int. – 2016. – V. 113. – No 7. – P. 107–113. DOI: 10.3238/arztebl.2016.0107.
15. Do V. et al. Sexual violence and the risk of HIV transmission in sexual partners of male injecting drug users in Tien Du district, Bac Ninh province of Vietnam // Health Care Women Int. – 2018. – V. 39. – No 4. – P. 404–414. DOI: 10.1080/07399332.2017.1423315.
16. Liakoni E. Psychoactive substances and violent offences: A retrospective analysis of presentations to an urban emergency department in Switzerland // PLoS One. – 2018. – V. 13. – No 3. DOI: 10.1371/journal.pone.0195234.
17. Goldstein P. The drugs/violence nexus: A tripartite conceptual framework // J. Drug Issues. – 1985. – V. 15. – No 4. – P. 493–506.
18. Žarkovic P. Psychiatric comorbidity in forensic psychiatry // Psychiatria Danubina. – 2009. – V. 21. – No 3. – P. 429–436.
19. Coomber K. The role of illicit drug use in family and domestic violence in Australia // J. Interpers. Violence. – 2021. – V. 36. – No 15–16. – P. NP8247–NP8267. DOI: 10.1177/0886260519843288.
20. Substance Abuse and Mental Health Services Administration (SAMHSA) behavioral health trends in the United States: Results from the 2014 National Survey on Drug Use and Health. – 2014. URL: https://www.samhsa.gov/data/sites/default/files/NSDUH-FRR1-2014/NSDUH-FRR1-2014.htm
21. Mounteney J. et al. The drug situation in Europe: an overview of data available on illicit drugs and new psychoactive substances from European monitoring in 2015 // Addiction. – 2016. – V. 111. – № 1. – P. 34–48. DOI:10.1111/add.13056.
22. Stompe T. et al. Patterns of substance abuse in offenders with schizophrenia: illness-related or criminal life-style? // Frontiers in Psychiatry. – 2019. – V. 9. – P. 10. DOI: 10.3389/fpsyt.2018.00233.
23. Erkiran M. Substance abuse amplifies the risk for violence in schizophrenia spectrum disorder // Addict. Behav. – 2006. – V. 31. – P. 1797–1805. DOI: 10.1016/j.addbeh.2005.12.024.
24. Maremmani I. et al. Does dual diagnosis affect violence and moderate/superficial self-harm in heroin addiction at treatment entry? // J. Addict. Med. – 2014. – V. 8. – P. 116–122. DOI: 10.1097/ADM.0000000000000019.
25. Ataev D.A. et al. Bipolar disorder and drug addiction // Abstracts of the All-Russian scientific and practical conference of young scientists with international participation. – Moscow: FSBI DPO “TSGMA”. – 2023. – P. 11–13. In Russian.
26. Lewis C. Substance use and violent behavior in women with antisocial personality disorder // Behav. Sci. Law. – 2011. – V. 29. – P. 667–676. DOI: 10.1002/bsl.1006.
27. Corkery J. et al. Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1.4 butanediol (1.4-BD; BDO): a literature review with a focus on UK fatalities related to non-medical use // Neuroscience and Biobehavioral Reviews. – 2015. – V. 53. – P. 52–78. DOI: 10.1016/j.neubiorev.2015.03.012.
28. Corkery J. et al. Mephedrone-related fatalities in the United Kingdom: contextual, clinical and practical issues // Pharmacology Open Access Publisher. – 2012. – P. 355–380.
29. Chiappini S. et al. Methoxetamine-related deaths in the UK: an overview // Human Psychopharmacology: Clinical and Experimental. – 2015. – V. 30. – No 4. – P. 244–248. DOI: 10.1002/hup.2422.
30. Kuypers K. et al. Intoxicated aggression: Do alcohol and stimulants cause dose-related aggression? A review // Eur. Neuropsychopharmacol. – 2020. – V. 30. – P. 114–147. DOI: 10.1016/j.euroneuro.2018.06.001.
31. Gillet C. et al. Acting out and psychoactive substances: alcohol, drugs, illicit substances // Encephale. – 2001. – V. 27. – No 4. – P. 351–359. PMID: 11686057.
32. Vaughn M. et al. Crime and violence among MDMA Users in the United States // AIMS Public Health. – 2015. – V. 18. – No 2. – P. 64–73. DOI: 10.3934/publichealth.2015.1.64.
33. Wood D. et al. Prevalence of use and acute toxicity associated with the use of NBOMe drugs // Clin. Toxicol. – 2015. – V. 53. – P. 85–92. DOI: 10.3109/15563650.2015.1004179.
34. Saxon L. et al. Reduction of aggression during benzodiazepine withdrawal: Effects of flumazenil // Pharmacol. Biochem. Behav. – 2010. – V. 96. – No 2. – P. 148–151. DOI: 10.1016/j.pbb.2010.04.023.
35. Papanti D. “Spiceophrenia”: a systematic overview of “spice”-related psychopathological issues and a case report // Hum. Psychopharmacol. – 2013. – V. 28. – No 4. – P. 379–89. DOI: 10.1002/hup.2312.
36. Roberts L. 11 analytically confirmed cases of mexedrone use among polydrug users // Clin. Toxicol (Phila). – 2017. – V. 55. – No 3. – P. 181–186. DOI: 10.1080/15563650.2016.1271424.
37. Schifano F. et al. Psychonaut Web Mapping; ReDNet Research Groups. Mephedrone (4-methylmethcathinone; “meow meow”): chemical, pharmacological and clinical issues // Psychopharmacology (Berl). – 2011. – V. 214. – No 3. – P. 593–602. DOI: 10.1007/s00213-010-2070-x.
38. James D. et al. Clinical characteristics of mephedrone toxicity reported to the UK National Poisons Information Service // Emerg. Med. J. – 2011. – V. 28. – No 86. – P. 689. DOI: 10.1136/emj.2010.096636.
39. Schifano F. Substance misuse in the workplace. In: Ghodse A.H. (ed). Addiction at work: tackling drug use and misuse in the workplace // Gower Publishing Ltd, Aldershot (UK). – 2005. – P. 53–67.
40. Barthelemy O. Prenatal, perinatal, and adolescent exposure to marijuana: Relationships with aggressive behaviour // Neurotoxicol. Teratol. – 2016. – V. 58. – P. 60–77. DOI: 10.1016/j.ntt.2016.06.009.
41. Martinotti G. et al. Substance‐related psychopathology and aggressiveness in a nightlife holiday resort: Results from a pilot study in a psychiatric inpatient unit in Ibiza // Hum. Psychopharmacol. Clin. Exp. – 2017. – V. 32. – No 3. DOI: 10.1002/hup.2586.
42. Kolla N. et al. The endocannabinoid system, aggression, and the violence of synthetic cannabinoid use, borderline personality disorder, antisocial personality disorder, and other psychiatric disorders // Front. Behav. Neurosci. – 2018. – V. 12. – P. 41. DOI: 10.3389/fnbeh.2018.00041.
43. Brooks J. Serum testosterone in violent and nonviolent young offenders // J. Clin. Psychol. – 1996. – V. 52. – No 4. – P. 475–83. DOI: 10.1002/(SICI)1097-4679(199607)52:4<475::AID-JCLP14>3.0.CO;2-D.
44. Wang J. et al. Self-directed violence after medical emergency department visits among youth // Am. J. Prevent. Med. – 2019. – V. 56. – No 2. – P. 205–214. DOI: 10.1016/j.amepre.2018.09.014.
45. Mauri M. Aggression and psychopharmacological treatments in major psychosis and personality disorders during hospitalization // Progress in Neuro-Psychopharmacology and Biological Psychiatry. – 2011. – V. 35. – No 7. – P. 1631–1635. DOI: 10.1016/j.pnpbp.2011.05.008.
46. Swanson J. et al. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia // The British Journal of Psychiatry. – 2008. – V. 193. – No 1. – P. 37–43. DOI: 10.1192/bjp.bp.107.042630.
47. Martinotti G. et al. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients // Hum. Psychopharmacol. – 2007. – V. 22. – P. 149–156. DOI: 10.1002/hup.833.
48. Schifano F. NPS: Medical consequences associated with their intake // Curr. Top. Behav. Neurosci. – 2017. – V. 32. – P. 351–380. doi: 10.1007/7854_2016_15.
49. Iskandarov R.R. et al. Risk factors and predictors of aggressive behavior of convicted men with post-traumatic stress disorder // Social and Clinical Psychiatry. – 2013. – V. 23. – No 2. – P. 21 – 28. In Russian.
50. Vilkova A.V. et al. Psychological support of juvenile convicts in educational colonies of the penal correctional system of the Russian Federation // To the 80th anniversary of the birth of Doctor of Pedagogical Sciences, Professor V.M. Litvishkov: collection of materials of the round table. – Ryazan: FCU NIIT. – 2023. – P. 141–145. In Russian.
51. Balamut A.N. Conducting sessions on psychotherapeutic areas of work with different categories of inmates: a practical guide // Vologda Institute of Law and Economics. – Vologda: Vologda Institute of Law and Economics of the Federal Service for the Execution of Punishments. – 2017. – 97 p. In Russian.
52. Kryazheva S.G. Studying the personality of a life convict as a condition for effective operational and investigative prevention // Psychology and Law. – 2023. – V. 13. – No 2. – P. 127–142. DOI: 10.17759/psylaw.2023130210. In Russian. DOI:10.17759/psylaw.2023130210.